GIA
IONS icon

Gateway Investment Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Gateway Investment Advisers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-51,174
Closed -$1.93M – 531
2022
Q4 		$1.93M Buy
51,174
+975
+2% +$41K 0.02% 308
2022
Q3 		$2.22M Sell
50,199
-48,930
-49% -$2.06M 0.03% 303
2022
Q2 		$3.67M Hold
99,129
– – 0.04% 262
2022
Q1 		$3.67M Buy
99,129
+14,026
+16% +$459K 0.04% 278
2021
Q4 		$2.59M Buy
85,103
+46,971
+123% +$1.48M 0.02% 291
2021
Q3 		$1.28M Buy
38,132
+532
+1% +$20K 0.01% 349
2021
Q2 		$1.5M Hold
37,600
– – 0.02% 344
2021
Q1 		$1.69M Hold
37,600
– – 0.02% 333
2020
Q4 		$2.13M Hold
37,600
– – 0.02% 316
2020
Q3 		$1.78M Hold
37,600
– – 0.02% 316
2020
Q2 		$2.22M Sell
37,600
-38,876
-51% -$2.16M 0.03% 309
2020
Q1 		$3.62M Buy
76,476
+37,513
+96% +$2.09M 0.04% 248
2019
Q4 		$2.35M Sell
38,963
-3,283
-8% -$196K 0.02% 329
2019
Q3 		$2.53M Buy
42,246
+803
+2% +$52.3K 0.03% 338
2019
Q2 		$2.66M Buy
+41,443
New +$2.93M 0.02% 334

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Gateway Investment Advisers's IONS Position: Q1 2023 in Review

Gateway Investment Advisers sold out of Ionis Pharmaceuticals (IONS) in Q1 2023, closing a stake of 51,174 shares — an estimated $1.93M sold.

Gateway Investment Advisers first reported a position in IONS in Q2 2019 and held it in 15 quarters. The position peaked at $3.67M in Q1 2022. 313 funds tracked by Wall St. Rank hold IONS as of Q1 2023.

  • Gateway Investment Advisers reported no remaining Ionis Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Gateway Investment Advisers sold 51,174 Ionis Pharmaceuticals shares in Q1 2023, an estimated $1.93M.
  • Gateway Investment Advisers first reported a position in Ionis Pharmaceuticals in Q2 2019 and held it in 15 quarters.
  • Gateway Investment Advisers's Ionis Pharmaceuticals position peaked at $3.67M in Q1 2022.
  • 313 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2023.

Based on Gateway Investment Advisers's 13F filing for Q1 2023, filed 11 Apr 2023.